Memory
and Dementia
PKGhatak, MD
What
is memory.
Memory
is the ability to recall previously learned somatic sensory, visual, auditory, taste and smell sensations, abstract ideas, dreams,
subconscious experiences, and a combination of any of these, at an
instance when required. Memories result from nerve cell
reactivation, in specific areas of the brain, at various levels of
activities, and the role of the interconnecting pathways to the neurons
plays.
Location
of memory centers in the Brain.
Hippocampus.
Amygdala and Prefrontal Cortex are the chief memory centers.

Memories
are three different kinds. 1. Short term memory. 2. Permanent memory
and, 3. Working Memory.
Short
term memory.
Memories
are stored mainly in the Hippocampus and outlines of those experiences
are also kept in the prefrontal cortex at the same time. The gradual consolidation of memory takes place in the prefrontal cortex and
short term memory from the hippocampus disappears at the same rate. Others believe
permanent memory develops at the same time the short time memory is
developing in the hippocampus.
Permanent
memory.
The
prefrontal cortex, memory is known as the permanent memory.
Working
memory.
The
working memory is a complex short term memory where many other mental
faculties work in harmony for the execution of a work plan. Example:
driving an automobile to an address given to the driver over the
telephone.
What
is Dementia.
Dementia
is defined as loss of
memory, language, problem-solving and other thinking abilities that
are severe enough to interfere with daily life.
Incidence
of dementia in the USA.
The incidence of dementia among individuals aged 71 and older is about
14%. The incidence increases with increasing age.
Causes
of Dementia.
The
cause of dementia is due to the loss of function of memory cells due to disease or death.
Classification of Dementia.
The classification is based on the common link among the different
entities.
1. Progressive
dementia. Dementia is not reversible.
Example:
Alzheimer's disease, Lewy body dementia.
2.
Vascular dementia. Damage to the blood vessels and to memory centers of
the brain.
3.
Frontotemporal dementia. Degeneration of the nerve cells in the
frontotemporal cortex.
4.
Mixed dementia. Vascular dementia and progressive dementia often coexist.
5. Dementia
as a part of other diseases. Examples. a) Huntington's disease
b)
Traumatic Brain Injuries (TBI). c) Creutzfeldt-Jakob disease. d) Parkinson's disease
6.
Reversible dementia.
Subdural hematoma, normal pressure
hydrocephalus, certain medications taken for various illnesses, like antihistamines, antidepressants.
Alcoholism, Vitamin B1 and Vitamin B12 deficiency. Infections,
Hypothyroidism, hypoglycemia, Lead poisoning, Hypoxemia, and brain
tumors are some of the examples of reversible dementia.
7.
Inherited and familial. Huntington's disease, Down syndrome.
Alzheimer's disease.
Alzheimer's disease.
Alzheimer's disease (AD) is the
most common dementia in the elderly population. AD is an irreversible
and progressive disease. The onset of AD is insidious. The changes
in the brain begin years before the first signs of dementia. Forgetfulness is the earliest symptom, slowly and steadily
progressive loss of memory occurs, then progresses to loss of
cognitive function, motor skills, logical thinking, social isolation
and finally complete loss of activities of daily living develops.
Clinically AD is discussed under 1. Early,2. Moderately advanced and 3. Late stages based on the degree of
disability
Basic biological changes are due
to the accumulation of two abnormal proteins in the brain. Beta Amyloid
protein -- due to an abnormal gene of an Amyloid Precursor Protein (APP)
on chromosome 21. Apolipoprotein APOE 4 is produced
instead of normal APOE protein. The abnormal beta amyloid protein
accumulates between the microglia cells, astrocytes and neurons. The microglia cells, normally function as immunocytes of the brain and have phagocytic properties. They are unable to break
down the beta amyloid. Accumulated beta amyloid forms plaques. The connecting neuronal fibers
and synapses gradually lose function and neurons die, the brain shrinks in size.
The second abnormal protein is
Tau protein. TREM 2 gene encodes tau protein. This protein is present in the membrane receptors of microglia. The mutant TREM2 generated an abnormal tau protein - hyperphosphorylated, abnormally
folded protein, which destroys the
microtubules. Microtubules require ATP energy to transmit chemicals from one spot to the other within the cell. Hyperphosphorylations prevent microtubules from using ATP. Dying microglia release cytokines which further damage neurons.
Pathologically the loss of nerve
fibers, synapses, and neurons is most noticeable in the hippocampus, cingulate gyrus, temporal lobes and parietal lobes.
Diagnosis of AD.
Diseased and damaged areas of the brain are detected by MRI, CT scan and Positron Emission Tomogram
(PET) scan. A definitive diagnosis is made on brain tissue obtained by
biopsy or at autopsy. Neurofibrillary triangles and a decrease in the number of neurons are demonstrated. Beta amyloid and tau proteins are identified by staining.
Treatment.
Based on the clinical stage of
the disease management of AD varies. All aspects of medical
therapeutics, physiotherapy, occupational therapy, behavior
modifications, social integration and experimental treatment
modalities are employed.
Therapeutics.
Two groups of drugs are used in
the treatment of AD. 1. Acetylcholine esterase inhibitors. 2.
N-Methyl D Aspartate Receptor Antagonists (NMDAR).
Acetylcholine esterase
inhibitors. Acetylcholine is a neurotransmitter, in normal conditions, it is degraded from the
synapses by the enzyme acetylcholine esterase. Increasing the local
concentration of acetylcholine by blocking this enzyme shows some
improvement of memory at least initially. The commonly
prescribed drugs are Donepezil, Rivastigmine and Galantamine.
NMDAR. Glutamine is another neurotransmitter. But the excess accumulation of glutamine within the neuron
is harmful to neurons. NMDAR blocks glutamine uptake by neurons. The
approved drug is Memantine.
Prognosis. The prognosis of AD is
poor. It is the 6th
common cause of death in the USA.
Lewy Body Dementia (LBD)
Lewy body dementia is common in people over 50 years of age. An abnormal protein
alpha synuclein accumulates in neurons of the brain. The neurons swell
up with like a balloon due to accumulation of alpha synuclein. The neurotransmitters - Acetylcholine and Dopamine production are
diminished.
Acetylcholine deficiency causes a decline in cognition, behavior change
and alteration of sleep rhythm. Motor
function abnormality and rigidity like Parkinson's disease develop due to dopamine deficiency.
Areas of the brain affected in LBD
and consequences.
Neurons of the cerebral cortex –
defective reception, thought and language difficulties.
The limbic area of the brain - emotion
and behavior changes and fluctuations from time to time.
Hippocampus – difficulty in new
memory formation.
Brain stem – sleep disturbance
and fluctuating alertness.
Olfactory lobe – loss of smell
sensation or abnormal sense perception.
Distinguishing features of LBD
from other forms of dementia.
Fluctuating level of alertness. 2. Visual hallucination. 3. acting out dreams. 4. Gross impairment of abstract thinking and reasoning. 5. frequent episodes of delirium.
Risk factors.
Increasing age, presence of gene
mutation of APOE e4, SNCA and GBA genes,
Treatment.
No specific medication is
available for LBD. Symptomatic treatment is recommended. Prevention
of falls and fractures of bones requires special attention. In most
patients with various levels of assistance are required for activities of
daily living.
Prognosis. It is not good. From the
time of LBD diagnosis, most people die between 5 and 8 years.
Huntington's Disease (HD) and
Dementia.
Huntington's disease is an
autosomal dominant inherited disease. As the disease progresses, the
short term memory, permanent memory and work memory are all
profoundly lost, leading to dementia.
HD results due to the accumulation of
an abnormal protein - Mutant Huntingtin protein (mHTT) within the
neuron in a wide area of the brain but the highest concentration is present
in the Striatum. A moderate amount of accumulation of mHTT is present in
caudate nuclei, putamen, hippocampus, Purkinje cells of the motor
cortex, cerebellum, hypothalamus, and cerebral cortex.
The mHTT protein starts to
accumulate in the cells. It is broken down by the enzyme
Caspase. But the fragments quickly reform in a haphazard manner. This
abnormally folded mHTT protein structurally resembles beta amyloid
protein. The mHTT protein is present in both the nucleus and cytoplasm
of the neurons and is known as inclusion bodies. The mHTT protein is
toxic to the cells and results in cell death.
The mHTT protein deposition is also
seen in the heart, testicles, liver, and lungs and produces symptoms from the damaged tissues of these organs.
Huntington's Disease is an autosomal dominant
inheritance disease. A mutation of a gene in the short
arm of chromosome 4 is responsible for HD. The European population has more HD; the incidence is about 15
per 100,000 population. The symptoms of HD appear at ages 30 to 50
years of age. Less frequently, young adults in their 20s show signs of HD. Rigidity is the prominent symptom and features that resemble Parkinson's disease are present. In contrast to the older population, HD seizures are rare occurrences. But the disease progresses rapidly in the Juvenile form of
HD.
Some special features of HD.
Seizures are not unusual; the presence of a characteristic eye
movement is called saccadic eye movement. Muscle rigidity, incoordination, unstable gait resembles Parkinson's disease. Patients
are emotionally labile. An increased rate of suicide is noted.
Diagnosis. Detection of abnormal
chromosome 4 is essential. Siblings, children, and close relatives,
even with no symptoms of HD, can have chromosome analysis done to detect their chance of HD if they wish and properly counseled.
Treatment. In general, medications are prescribed for the control of symptoms and complications that arise from HD. No cure is possible at present. Stem cell transplants
are discussed but not performed.
For control chorea (abnormal purposeless dance-like movements) in HD, Tetrabenazine is approved.
Prognosis. For most patients, deaths usually take place in 15 to 20 years.
Dementia of Parkinson's disease (PD).
Parkinson's disease is a
progressive, irreversible degenerative disease of the brain.
Substantial nigra is primarily affected and results in a decrease in
Dopamine production from the deaths of the neurons. About 2 % of
people over 65 have Parkinson's disease.
Older PD patients with dementia suffer from repeated
hallucinations and excessive daytime sleepiness.
Some special symptoms associated
with dementia of Parkinson's disease.
Delusions and paranoid ideas are
common, have difficulty in interpreting visual images, display
conceptual memory loss, and react adversely to antipsychotic drugs,
often lapsing into coma from their use.
Frontotemporal Dementia.
Of all the different causes of
dementia, frontotemporal dementia has the most devastating impact
on the patient and the family. Frontotemporal dementia appears at
age 40, the incidence is equal in both sexes, has a strong family history and is inherited due to multiple genetic defects. The disease involves
degeneration of neurons due to the accumulation of an abnormal protein,
pink bodies in the neurons, involving many areas of the brain
simultaneously, including the Limbic area and the Neocortex.
Features of frontotemporal dementia (FTD).
Abnormal behavior like stealing,
swearing, excessive indulgence in sexual activities, apathy, language
difficulties, halting speech, and carelessness about personal
hygiene. Some develop poor muscle coordination, tremors, muscle
spasms and swallowing difficulty. Hallucinations and delusions are
present in others.
Classification of FTD.
Frontal variant where behavioral
changes predominate. In Primary progressive aphasia- semantic
dementia patients have great difficulties in understanding spoken
words and initiating a conversation due to delayed speech. Degenerative diseases of the nervous system like Amyotrophic lateral sclerosis may also have this dementia.
Diagnosis of FTD.
The neuropsychological examination is
the first step followed by an MRI or CT scan of the brain demonstrating
multiple areas of involvement including the center of primitive functions
in the Limbic area and behavior modification areas in the neocortex.
Treatment.
No treatment can change the basic
defect in the brain, but symptomatic treatment can control some
symptoms.
Vascular Dementia.
Vascular dementia develops due to
diseases of cerebral blood vessels.
One major event, like strokes, may
produce dementia or dementia
follows from many mini strokes or vascular insufficiency. The symptoms of vascular dementia are variable
based on the areas of the brain that are damaged. Dementia is a dominant
symptom when the hippocampus and prefrontal area of the cortex of the brain bear
the brunt of anoxia.
Predominant symptoms of vascular
dementia are confusion, restlessness and agitation, poor attention
span and mixed memory loss.
Risk factors include high blood
pressure, cigarette smoking, drug use, diabetes mellitus, obesity and
high blood cholesterol and triglycerides.
Treatment.
The main goal of therapy is to
prevent further neurological episodes. Risk factors reduction, rehabilitation
and symptomatic treatment.
Dementia associated with
Traumatic Brain Injury.
Because of wide circulation in print media
and electronic media regarding traumatic brain injury and its
consequences, Traumatic brain injury (TBI) is a familiar
subject. The attention of the public was drawn to this subject when
Mohammad Ali, the famous heavyweight boxing legend, developed
Parkinson's disease. More news soon followed detailing
accounts of veterans struggling with this poorly understood entity at
that time and also because of the news that many veterans committed suicide.
Professional players engaged in
contact sports, college football players and others, who have sustained blows
to the head resulting in concussion or unconsciousness or amnesia,
later developed a symptom complex known as Chronic Traumatic Encephalopathy (CTE). Dementia is a part of the CTE
symptoms.
Incidence. About 2 % of the adult
population is known to have CTE. About 50% of CTE patients have a history of loss of consciousness.
Inheritance. The incidence of
CTE is 10 times higher when the abnormal AOPE e4 gene is
present. The mode of inheritance is not known, probably multiple gene
mutations are possible.
Pathology. Beta amyloid protein,
Tau protein, accumulation in the brain of 30 % CTE
patients detected by autopsy examination. The most common areas of the brain
showing abnormality are the hippocampus, amygdala, precuneus, parietal
and frontal lobes of the brain.
Distinguishing features of CTE
are headaches, sudden mood swings, explosive rage, drug abuse and
suicide. Ataxia, dysarthria, rigidity and tremor are evident
during examinations.
Treatment. Multidisciplinary
medical therapies including psychological counseling are called for. The
outcome of coordinated therapy is encouraging.
**********************************************************